Chemical formula: C₁₃H₁₆ClNO Molecular mass: 237.73 g/mol PubChem compound: 182137
Esketamine is indicated for:
Population group: only adults (18 - 65 years old)
Esketamine, in combination with a SSRI or SNRI, is indicated for adults with treatment-resistant Major Depressive Disorder, who have not responded to at least two different treatments with antidepressants in the current moderate to severe depressive episode.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only elderly (65 years old or older)
Esketamine, in combination with a SSRI or SNRI, is indicated for adults with treatment-resistant Major Depressive Disorder, who have not responded to at least two different treatments with antidepressants in the current moderate to severe depressive episode.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Esketamine is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
